Financhill
Back

Dermata Therapeutics Quote, Financials, Valuation and Earnings

Dermata Therapeutics Price Quote

$1.16
-0.07 (-5.7%)
(Updated: November 14, 2024 at 5:55 PM ET)

Dermata Therapeutics Key Stats

Sell
20
Dermata Therapeutics (DRMA) is a Sell

Day range:
$1.23 - $1.30
52-week range:
$1.20 - $14.63
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.49%

Volume:
47.6K
Avg. volume:
152.4K
1-year change:
-87.76%
Market cap:
$1.6M
Revenue:
$0
EPS:
$-27.47

How Much Does Dermata Therapeutics Make?

Data Unavailable

Is Dermata Therapeutics Growing As A Company?

Data Unavailable

Dermata Therapeutics Stock Price Performance

What Is Dermata Therapeutics 52-Week High & Low?

Dermata Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Dermata Therapeutics?

Is Dermata Therapeutics Cash Flow Positive?

  • What Is DRMA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$7.7M
  • What Is Dermata Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $4.3M
  • What Is Dermata Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Dermata Therapeutics Return On Invested Capital

Data Unavailable

Dermata Therapeutics Earnings Date & Stock Price

Dermata Therapeutics Competitors

Dermata Therapeutics Dividend Yield

Dermata Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 6.00
Upside from Last Price: 387.77%

Major Shareholders

  • How many DRMA shares are owned by institutional investors?
    38.3K DRMA shares are owned by institutional investors
  • How many DRMA shares are owned by insiders?
    351.5K DRMA shares are owned by insiders